Hypothermia and Shivering

Last updated: March 9, 2026
Table Of Contents

Hypothermia

Hypothermia is defined as a core body temperature less than 36 degrees Celsius. Core body temperature can be measured in the nasopharynx, distal eosophagus, tympanic membrane and pulmonary artery. Skin is generally much cooler than core temperature.

  • Pathway of thermoregulation
    • Afferent nerves travel along A-delta (cold) and C (warm) fibres via the spinothalamic tract → pre-processing occurs in the spinal cord and brainstem → thermal inputs ultimately reach the pre-optic anterior hypothalamus

Mechanisms to control body temperature

ResponseExamples
BehavioralSeeking shelter or clothing, voluntary movement
AutonomicShivering, Sweating, Modulating vascular tone

Interthreshold range: the core temperature range between cold-induced and warm-induced responses, usually as narrow as 0.2 C.

Anaesthesia increases the interthreshold range

Effects of Anaesthesia on the interthreshold range

AnaesthesiaEffect
General anaesthesiainhibits thermoregulation globally. Increases interthreshold range 20-fold to around 4 C.
Regional anaesthesiainhibits thermoregulation to the lower half of the body. Increases interthreshold range 4-fold (around 0.8 C)

Phases of Anaesthetic impaired thermoregulation

PhaseEvent
Phase IRedistribution hypothermia
Phase IIHeat loss > heat production
Phase IIIHeat loss – heat production. Heat balance is at steady state
  • Heat transfer in the operating room (in order of importance)
    • Radiation
    • Convection
    • Evaporation
    • Conduction
  • Benefits of hypotehrmia
    • Decreases metabolic rate by 8% per 1 C decrease in body temperature: myocardial protection
    • Partial protection to the CNS from ischemic and traumatic injuries: improved neurologic outcome after cardiac arrest and allows deep hypothermic circulatory arrest for certain cardiac surgeries (complex aortic arch repair)
    • Protection against malignant hyperthermia
  • Disadvantages of Hypothermia
    • Increases infection rates up to 3 fold
    • Delays wound healing and increases risk of surgical graft failure
    • Induces coagulopathy (part of the trauma lethal triad)
    • Delays emergence from general anaesthesia
    • Impairs oxygen delivery by causing left-shift of the oxygen-hemoglobin dissociation curve
    • Negative effect on ionotropy and chronotropy, increases EKG interval, leads to dysrhythmias, and increased systemic vascular resistance
    • Increases systemic stress response
    • Increases post-operative shivering rates
    • Prolonges PACU stay

Warming strategies – prevention of hypothermia is more effective than treatment

StrategyExamples
Active warmingForced air, Heating pad with circulating water, Breathing circuit heating and humidification, IV Fluid Warmer, Bladder Irrigation with warm fluids, Heating lamp, Raise room temp
Passive InsulationCotton blanket, surgical drapes, heat-reflective “space” blanket

Shivering

  • Causes of shivering in PACU
    • Hypothermia (keep in mind that lack of shivering does not mean the patient is hypothermic. Remember opioids and anesthetics can increase the interthreshold range)
    • Uncontrolled pain (non-thermoregulatory driven shivering)
  • Other differentials for rhythmic muscular activities
    • Pure clonic movements (seen in patients as volatile MAC drops to 0.15 – 0.3 range regardless of temperature)
    • Fevers
    • Seizures
  • Effects of shivering
    • Increases Oxygen consumption (upto 500 % increase)
    • Increases CO2 production (this increases minute ventilation requirment)
    • Associated with trauma, elevated intraocular pressure, and elevated intracranial pressure
    • Can be distressing or painful
    • Disrupts monitoring (oscillometric BP measurement and pulse oximetry)
  • Treatment of shivering
    • Warm the patient aggressively (forced air and blankets)
    • Meperedine 12.5 – 25 mg IV (note that meperedine can accumulate in renal insufficiency leading to seizures)
    • NDMB (only in anaesthetized and mechanically ventilated patients)
    • Ensure pain is well controlled
    • Ensure the patient is not seizing
  • What is the most effective way to reduce the amount of heat lost due to redistribution from core to periphery during the first 30 minutes after induction?
    • Pre-operative forced air warming to torso and legs 30 min before induction
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *